These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10468026)

  • 41. Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
    Lemmer B; Wiethold G; Hellenbrecht D; Bak IJ; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(3):299-313. PubMed ID: 4143918
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of selected beta-blockers on social interaction of rhesus monkeys.
    Jaekel J
    Act Nerv Super (Praha); 1982; Suppl 3(Pt 2):528. PubMed ID: 6134420
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Apr; 26(7):603-8. PubMed ID: 4144788
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative partial agonist activity of -adrenoceptor antagonists.
    Nayler WG
    Br J Pharmacol; 1972 Jun; 45(2):382-4. PubMed ID: 4403104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of adrenergic drugs on ciliary epithelium.
    Deshpande VR; Chandorkar AG; Balsara JJ
    Indian J Physiol Pharmacol; 1970 Jul; 14(3):175-9. PubMed ID: 4400783
    [No Abstract]   [Full Text] [Related]  

  • 46. Interference of beta-blocking drugs with cortisol determinations.
    Radó JP; Végh L
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):5-6. PubMed ID: 14077
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
    Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of beta-blocking agents.
    Goldstein RE
    Circulation; 1973 Mar; 47(3):443-5. PubMed ID: 4144218
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
    [No Abstract]   [Full Text] [Related]  

  • 52. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Permeation enhancers in the transmucosal delivery of macromolecules.
    Sharma S; Kulkarni J; Pawar AP
    Pharmazie; 2006 Jun; 61(6):495-504. PubMed ID: 16826967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of calcium depletion as a strategy for enhancement of mucosal absorption of macromolecules.
    Vllasaliu D; Shubber S; Garnett M; Alexander C; Eaton M; Stolnik S
    Biochem Biophys Res Commun; 2012 Feb; 418(1):128-33. PubMed ID: 22245426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
    Porotikov VI; Cherenshchikova EA; Filippov AK; Mashkovskiĭ MD; Iuzhakov SD
    Biull Eksp Biol Med; 1984 Jun; 97(6):677-9. PubMed ID: 6146358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.
    Weber MA; Thornell IR; Stokes GS
    J Pharmacol Exp Ther; 1974 Jan; 188(1):234-40. PubMed ID: 4148935
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus.
    Schechter Y; Weinstock M
    Br J Pharmacol; 1974 Oct; 52(2):283-7. PubMed ID: 4155992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The slug mucosal irritation (SMI) assay: development of a screening tool for the evaluation of ocular discomfort caused by shampoos.
    Lenoir J; Claerhout I; Kestelyn P; Klomp A; Remon JP; Adriaens E
    Toxicol In Vitro; 2011 Dec; 25(8):1919-25. PubMed ID: 21741469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.